Furthermore, examination of MACC1 expression levels in tumor tissues of various clinical stages has revealed that the highest MACC1 expression level has been observed more often in malignant tumor tissues of patients, who frequently demonstrate more unfavorable clinicopathological features including enhanced lymphnode metastasis and metachronously developed distant metastases. The gene discussed is MACC1; the disease is cancer.